Get the Stockscreener App
6.68
2.14%
0.14
After Hours:
6.68
Shattuck Labs Inc stock is traded at $6.68, with a volume of 441.76K.
It is up +2.14% in the last 24 hours and down -1.47% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$6.54
Open:
$6.5
24h Volume:
441.76K
Relative Volume:
0.86
Market Cap:
$504.89M
Revenue:
$1,000.00K
Net Income/Loss:
$-48.81M
P/E Ratio:
-8.6338
EPS:
-0.7737
Net Cash Flow:
$-39.95M
1W Performance:
-5.78%
1M Performance:
-1.47%
6M Performance:
+240.82%
1Y Performance:
+667.73%
1-Day Range:
$6.33
$6.76
1-Week Range:
$6.33
$7.77
52-Week Range:
$0.712
$8.33
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
6.68 | 494.30M | 1,000.00K | -48.81M | -39.95M | -0.7737 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-27-26 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-26 | Resumed | Needham | Buy |
| Jan-28-26 | Initiated | Piper Sandler | Overweight |
| Dec-01-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-08-25 | Initiated | Wedbush | Outperform |
| Mar-17-25 | Initiated | Leerink Partners | Outperform |
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
Shattuck Labs Stock Surges Following Positive Analyst Coverage - HarianBasis.co
Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK) - Insider Monkey
STTK Stock Price, Quote & Chart | SHATTUCK LABS INC (NASDAQ:STTK) - ChartMill
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL) and Shattuck Labs (STTK) - The Globe and Mail
Shattuck Labs (STTK) to Release Earnings on Thursday - MarketBeat
5 Best Performing Small Cap Stocks So Far in 2026 - Insider Monkey
Cantor Fitzgerald initiates coverage of Shattuck Labs (STTK) with overweight recommendation - MSN
Shattuck Labs (STTK) price target increased by 24.00% to 12.65 - MSN
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
STTK Initiated Coverage by Cantor Fitzgerald -- Rating Set to Ov - GuruFocus
STTK Initiated Coverage by Cantor Fitzgerald -- Rating Set to Overweight - GuruFocus
HC Wainwright Forecasts Stronger Earnings for Shattuck Labs - MarketBeat
Shattuck Labs (NASDAQ:STTK) Hits New 1-Year HighTime to Buy? - MarketBeat
STTK Shattuck Labs posts narrower Q4 2025 loss than forecasts, shares climb 4.65 percent on positive investor sentiment.Annual Summary - Newser
H.C. Wainwright Maintains Shattuck Labs(STTK.US) With Buy Rating, Raises Target Price to $18 - Moomoo
Shattuck Labs (NASDAQ:STTK) Stock Price Up 6%What's Next? - MarketBeat
STTK Maintained by HC Wainwright & Co. -- Price Target Raised to $18 - GuruFocus
Shattuck Labs (STTK) Stock High Frequency (Skyrockets) 2026-04-20Stock Idea Sharing Hub - Cổng thông tin điện tử tỉnh Lào Cai
Shattuck Labs (STTK) Stock Pending Order (Tick Up) 2026-04-18Community Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Needham Maintains Shattuck Labs(STTK.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Street Watch: What is the cash position of Shattuck Labs IncStock Surge & Risk Controlled Daily Plans - baoquankhu1.vn
Piper Sandler Maintains Shattuck Labs(STTK.US) With Buy Rating, Maintains Target Price $15 - 富途牛牛
How expensive is Shattuck Labs (STTK) Stock now | Price at $6.97, Up 0.72%Turnaround Stocks - Newser
Shattuck Labs (STTK) price target increased by 37.93% to 10.20 - MSN
Aberdeen Group plc Buys 436,673 Shares of Shattuck Labs, Inc. $STTK - MarketBeat
Shattuck Labs Stock Surges 8.4% on Analyst Optimism - National Today
Shattuck Labs (NASDAQ:STTK) Trading Up 8.4%Here's Why - MarketBeat
Aug Retail: Is Shattuck Labs Inc stock suitable for long term investing2026 Technicals & Expert-Curated Trade Recommendations - baoquankhu1.vn
[ARS] Shattuck Labs, Inc. SEC Filing - Stock Titan
Shattuck Labs (NASDAQ: STTK) seeks approval of revamped equity plan at 2026 virtual meeting - Stock Titan
Shattuck Labs Announces Participation in Upcoming March Investor Conferences - 富途牛牛
Investor Mood: Is Shattuck Labs Inc a turnaround story2026 Final Week & High Conviction Investment Ideas - baoquankhu1.vn
STTK.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
STTK Should I Buy - Intellectia AI
STTK News & Events - Intellectia AI
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
STTK.O Technical Analysis & Stock Price Forecast - Intellectia AI
Aug Catalysts: Is Shattuck Labs Inc a top pick in the sectorLong Setup & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Breakouts Watch: Is Shattuck Labs Inc stock a value trap2026 Retail & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
STTK PE Ratio & Valuation, Is STTK Overvalued - Intellectia AI
Shattuck Labs (NASDAQ:STTK) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Shattuck Labs: Surviving In An AI World Is Going To Be Tough (NASDAQ:STTK) - Seeking Alpha
Gap Down: Will Shattuck Labs Inc stock benefit from M AEarnings Growth Report & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Aug Wrap: Can Shattuck Labs Inc navigate macro headwinds2026 Trade Ideas & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Institution Moves: Is Shattuck Labs Inc a turnaround story2026 Bull vs Bear & Accurate Intraday Trading Signals - baoquankhu1.vn
MACD Signal: Will Shattuck Labs Inc benefit from green energy policies2026 Fundamental Recap & Target Return Focused Picks - baoquankhu1.vn
FOMO Trade: Is Shattuck Labs Inc stock a value trap2026 Levels & Weekly High Potential Stock Alerts - baoquankhu1.vn
Aug PostEarnings: What are the risks of holding Shattuck Labs Inc2026 Trading Recap & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Profit Recap: What is the target price for Stardust Power Inc stockEarnings Summary Report & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):